Gregory Russotti
Chief Tech/Sci/R&D Officer at CENTURY THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Gregory Russotti is currently an Advisor at Dynamk Capital LLC and the Chief Technology & Manufacturing Officer at Century Therapeutics, Inc. He previously worked at Celgene Corp.
as the VP of Cell Therapy Development and Operations from 2013 to 2019.
Dr. Russotti holds a doctorate degree from Rutgers State University of New Jersey, as well as undergraduate and graduate degrees from Rensselaer Polytechnic Institute.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-19 | 380,092 ( 0.59% ) | 1 M $ | 2024-04-29 |
Gregory Russotti active positions
| Companies | Position | Start |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Dynamk Capital LLC
 Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York. | Consultant / Advisor | - |
Former positions of Gregory Russotti
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 2019-12-30 |
Training of Gregory Russotti
| Rensselaer Polytechnic Institute | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CENTURY THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Dynamk Capital LLC
Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York. | Finance |
- Stock Market
- Insiders
- Gregory Russotti
